BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30479669)

  • 1. Hypoglycemia incidence and awareness among insulin-treated patients with diabetes: the HAT study in Brazil.
    Lamounier RN; Geloneze B; Leite SO; Montenegro R; Zajdenverg L; Fernandes M; de Oliveira Griciunas F; Ermetice MN; Chacra AR;
    Diabetol Metab Syndr; 2018; 10():83. PubMed ID: 30479669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycemia awareness among insulin-treated patients with diabetes in Malaysia: A cohort subanalysis of the HAT study.
    Hussein Z; Kamaruddin NA; Chan SP; Jain A; Uppal S; Bebakar WMW;
    Diabetes Res Clin Pract; 2017 Nov; 133():40-49. PubMed ID: 28888148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indonesia Cohort of IO HAT Study to Evaluate Diabetes Management, Control, and Complications in Retrospective and Prospective Periods Among Insulin-Treated Patients with Type 1 and Type 2 Diabetes.
    Rudijanto A; Saraswati MR; Yunir E; Kumala P; Puteri HH; Mandang VV
    Acta Med Indones; 2018 Jan; 50(1):26-37. PubMed ID: 29686173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-reported hypoglycaemia in insulin-treated patients with diabetes mellitus: results from the Singapore cohort of the International Operations Hypoglycaemia Assessment Tool study.
    Tan NC; Goh SY; Khoo EY; Dalan R; Koong A; Khoo CM; Tan TS; Jain AB; Gadekar AV; Bee YM;
    Singapore Med J; 2020 Mar; 61(3):129-136. PubMed ID: 32488272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An international survey on hypoglycemia among insulin-treated type I and type II diabetes patients: Turkey cohort of the non-interventional IO HAT study.
    Emral R; Tetiker T; Sahin I; Sari R; Kaya A; Yetkin İ; Cil SU; Tütüncü NB;
    BMC Endocr Disord; 2018 Feb; 18(1):9. PubMed ID: 29433560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported frequency, awareness and patient-physician communication of hypoglycaemia in Belgium.
    Peene B; D'Hooge D; Vandebrouck T; Mathieu C
    Acta Clin Belg; 2014 Dec; 69(6):439-45. PubMed ID: 25212241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Basal insulin glargine using a basal-bolus regimen in a common clinical practice: observational, non-interventional, multicenter, national project LINDA (Lantus in daily practice - safety and efficacy in basal bolus regimen)].
    Zďarská DJ; Brož J; Křivská B; Rušavý Z; Kvapil M
    Vnitr Lek; 2014 Sep; 60(9):712-9. PubMed ID: 25294758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-Reported Hypoglycemia in Insulin-Treated Patients with Diabetes: Results from the Philippine Cohort of the International Operations Hypoglycemia Assessment Tool (IO HAT) Study.
    Mirasol R; Nicodemus N; Jain A; Gadekar AV; Yu-Gan S
    J ASEAN Fed Endocr Soc; 2018; 33(1):12-21. PubMed ID: 33442106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Incidence of Hypoglycemia among Insulin-Treated Patients with Type 1 or Type 2 Diabetes: Bangladeshi Cohort of International Operations-Hypoglycemia Assessment Tool Study.
    Pathan MF; Fariduddin M; Nazimuddin K; Mollah AS; Islam Siddiqui MN; Hassan KA; Ferdous HS; Rahman MH; Ashrafuzzaman SM; Sobhan MJ; E-Tanvir Haider MR; Amin MF
    Indian J Endocrinol Metab; 2018; 22(3):379-386. PubMed ID: 30090731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries.
    Haluzik M; Kretowski A; Strojek K; Czupryniak L; Janez A; Kempler P; Andel M; Tankova T; Boyanov M; Smircic Duvnjak L; Madacsy L; Tarnowska I; Zychma M; Lalic N
    Diabetes Ther; 2018 Apr; 9(2):727-741. PubMed ID: 29524189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety and effectiveness of biosimilar insulin glargine in Japanese patients with diabetes mellitus in routine clinical practice: results of a post-marketing safety study.
    Shingaki T; Taki K; Koyanagi M; Nagaoka S; Yoshizawa K; Oki N; Yoshikawa A; Imaoka T
    Curr Med Res Opin; 2020 Jun; 36(6):947-958. PubMed ID: 32271092
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypoglycaemia Among Insulin-Treated Patients with Diabetes: Evaluation of the United Arab Emirates cohort of the International Operations-Hypoglycaemia Assessment Tool study.
    Abusnana S; Beshyah SA; Al-Mutawa N; Tahhan R; Jallo M; Arora R; Aly H; Singhal S
    Sultan Qaboos Univ Med J; 2018 Nov; 18(4):e447-e454. PubMed ID: 30988962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study.
    Cariou B; Fontaine P; Eschwege E; Lièvre M; Gouet D; Huet D; Madani S; Lavigne S; Charbonnel B
    Diabetes Metab; 2015 Apr; 41(2):116-25. PubMed ID: 25465273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Risk of Severe Hypoglycemic Events with Increasing Frequency of Non-severe Hypoglycemic Events in Patients with Type 1 and Type 2 Diabetes.
    Sreenan S; Andersen M; Thorsted BL; Wolden ML; Evans M
    Diabetes Ther; 2014 Dec; 5(2):447-58. PubMed ID: 25023521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence rate and risk factors for hypoglycemia among individuals with type 1 diabetes or type 2 diabetes in China receiving insulin treatment.
    Chen S; Lu J; Peng D; Liu F; Lu W; Zhu W; Bao Y; Zhou J; Jia W
    Diabetes Res Clin Pract; 2023 Dec; 206():110987. PubMed ID: 37925076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WHICH FACTORS MAY AFFECT THE QUALITY OF LIFE IN PATIENTS WITH TYPE 1 DIABETES MELLITUS USING THE MEDTRONIC VEO CONTINUOUS SUBCUTANEOUS INSULIN INFUSION PUMP?
    Thomakos P; Panagopoulos G; Kepaptsoglou O; Zoupas C; Mitrakou A
    Georgian Med News; 2018 Apr; (277):61-67. PubMed ID: 29745917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of patient-reported non-severe hypoglycemia on healthcare resource use, work-time loss, and wellbeing in insulin-treated patients with diabetes in seven European countries.
    Geelhoed-Duijvestijn PH; Pedersen-Bjergaard U; Weitgasser R; Lahtela J; Jensen MM; Östenson CG
    J Med Econ; 2013 Dec; 16(12):1453-61. PubMed ID: 24144009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting: modeling analysis.
    Tunis SL; Minshall ME; Conner C; McCormick JI; Kapor J; Yale JF; Groleau D
    Curr Med Res Opin; 2009 May; 25(5):1273-84. PubMed ID: 19366302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported frequency and impact of hypoglycemic events in Spain.
    Orozco-Beltrán D; Mezquita-Raya P; Ramírez de Arellano A; Galán M
    Diabetes Ther; 2014 Jun; 5(1):155-68. PubMed ID: 24515748
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.